Top Markets
Coin of the day
PhaseRx, Inc. PhaseRx, Inc.

PhaseRx, Inc.

PZRXQ
Rang in aandelen #42474
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments... PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$1.17K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel PhaseRx, Inc. (PZRXQ)

Categorie

Koersgeschiedenis voor PhaseRx, Inc. (PZRXQ)
Hoogste slotkoers: $0.00 op 2026-08-01

Laagste slotkoers: $5.21 op 2016-05-01
Koersgeschiedenis van PhaseRx, Inc. van 2016 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 0.00%
2025 -52.25%
2024 0.00%
2023 100.00%
2022 -4.35%
2021 -96.33%
2020 62.38%
2019 -37.88%
2018 -99.53%
2017 -62.39%
2016 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR